1. Home
  2. HALO vs MORN Comparison

HALO vs MORN Comparison

Compare HALO & MORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • MORN
  • Stock Information
  • Founded
  • HALO 1998
  • MORN 1984
  • Country
  • HALO United States
  • MORN United States
  • Employees
  • HALO N/A
  • MORN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • MORN Investment Managers
  • Sector
  • HALO Health Care
  • MORN Finance
  • Exchange
  • HALO Nasdaq
  • MORN Nasdaq
  • Market Cap
  • HALO 7.6B
  • MORN 9.0B
  • IPO Year
  • HALO N/A
  • MORN 2005
  • Fundamental
  • Price
  • HALO $66.96
  • MORN $214.77
  • Analyst Decision
  • HALO Buy
  • MORN Buy
  • Analyst Count
  • HALO 11
  • MORN 2
  • Target Price
  • HALO $73.09
  • MORN $347.50
  • AVG Volume (30 Days)
  • HALO 2.2M
  • MORN 441.8K
  • Earning Date
  • HALO 11-04-2025
  • MORN 10-29-2025
  • Dividend Yield
  • HALO N/A
  • MORN 0.85%
  • EPS Growth
  • HALO 68.93
  • MORN 64.83
  • EPS
  • HALO 4.37
  • MORN 9.41
  • Revenue
  • HALO $1,178,672,000.00
  • MORN $2,347,400,000.00
  • Revenue This Year
  • HALO $32.57
  • MORN $8.04
  • Revenue Next Year
  • HALO $23.77
  • MORN $7.65
  • P/E Ratio
  • HALO $15.35
  • MORN $22.81
  • Revenue Growth
  • HALO 34.97
  • MORN 8.23
  • 52 Week Low
  • HALO $42.01
  • MORN $210.02
  • 52 Week High
  • HALO $79.50
  • MORN $365.00
  • Technical
  • Relative Strength Index (RSI)
  • HALO 41.47
  • MORN 28.55
  • Support Level
  • HALO $63.80
  • MORN $210.02
  • Resistance Level
  • HALO $68.00
  • MORN $227.51
  • Average True Range (ATR)
  • HALO 2.30
  • MORN 4.77
  • MACD
  • HALO -0.48
  • MORN -0.23
  • Stochastic Oscillator
  • HALO 25.24
  • MORN 19.07

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

Share on Social Networks: